{"content":"<li class=\"n-box-item date-title\" data-end=\"1538539199\" data-start=\"1538452800\" data-txt=\"Monday, December 23, 2019\">Tuesday, October  2, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3394638\" data-ts=\"1538516063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELGX\" target=\"_blank\">ELGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394638-after-hours-gainers-losers-10-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (10/02/2018)</a></h4><ul><li><b>Top Gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a>&nbsp;<font color='green'>+30.2%</font>. <a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a> <font color='green'>+17.7%</font>. <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='green'>+16.0%</font>. <a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a> <font color='green'>+8.5%</font>. <a href='https://seekingalpha.com/symbol/CLSK' title='Cleanspark, Inc.'>OTCQB:CLSK</a>&nbsp;<font color='green'>+5.2%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='red'>-13.4%</font>. <a href='https://seekingalpha.com/symbol/KALA' title='Kala Pharmaceuticals'>KALA</a> <font color='red'>-8.5%</font>. <a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme'>EPZM</a>&nbsp;<font color='red'>-7.3%.</font>&nbsp;<a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/EPE' title='EP Energy Corporation'>EPE</a> <font color='red'>-2.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394638\" data-linked=\"After Hours Gainers / Losers (10/02/2018)\" data-tweet=\"$ELGX $ELGX $TRVN - After Hours Gainers / Losers (10/02/2018) https://seekingalpha.com/news/3394638-after-hours-gainers-losers-10-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3394638-after-hours-gainers-losers-10-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394635\" data-ts=\"1538514975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394635-intel-gains-amd-plunges-analyst-predicts-faster-10nm-ramp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel gains, AMD plunges as analyst predicts faster 10nm ramp</a></h4><ul><li>        BlueFin Research Partners <a href=\"https://www.bloomberg.com/news/articles/2018-10-02/intel-gain-brings-amd-pain-as-report-touts-10-nanometer-strides\" target=\"_blank\">says</a> Intel&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) 10nm production ramp could begin as early as April, up to six months earlier than current estimates.</li><li>               The firm says Intel is making &ldquo;significant strides&rdquo; towards its yield target, prompting supplier discussions about whether the ramp could happen before next June.&nbsp;</li><li>               Intel shares closed today&nbsp;<font color='green'>up 3.6%</font>&nbsp;to $48.10 and gained&nbsp;<font color='green'>0.1%&nbsp;</font>aftermarket.&nbsp;</li><li>               Rival AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) closed&nbsp;<font color='red'>down 7.6%</font>&nbsp;to $29.02 and&nbsp;<font color='red'>drops 0.3%&nbsp;</font>after hours. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393776-amd-minus-4_5-percent-intels-10nm-supply-update\" target=\"_blank\">AMD -4.5% on Intel's 10nm supply update</a> (Sept. 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393958-intel-amd-drop-analysts-cut-expectations\" target=\"_blank\">Intel, AMD drop as analysts cut expectations</a> (Oct. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394635\" data-linked=\"Intel gains, AMD plunges as analyst predicts faster 10nm ramp\" data-tweet=\"$INTC $INTC $AMD - Intel gains, AMD plunges as analyst predicts faster 10nm ramp https://seekingalpha.com/news/3394635-intel-gains-amd-plunges-analyst-predicts-faster-10nm-ramp?source=tweet\" data-url=\"https://seekingalpha.com/news/3394635-intel-gains-amd-plunges-analyst-predicts-faster-10nm-ramp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>332&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394630\" data-ts=\"1538514334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LSCC\" target=\"_blank\">LSCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394630-lattice-semi-closesplus-6_7-on-price-target-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lattice Semi closes +6.7% on price target boost</a></h4><ul><li>        Lattice Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/LSCC' title='Lattice Semiconductor Corporation'>LSCC</a>) closed today&nbsp;<font color='green'>up 6.7%</font>&nbsp;after Susquehanna raised its price target from $7 to $8. The rating was maintained at Neutral. (Source: StreetAccount).</li><li>                  In late August, Lattice appointed AMD&rsquo;s Jim Anderson as CEO. Anderson had served as the GM and senior VP of AMD&rsquo;s Computing and Graphics business group.    </li><li>               Lattice shares are&nbsp;<font color='green'>up 4.4%</font>&nbsp;in the past month,&nbsp;<font color='green'>34.7%</font>&nbsp;in the quarter, and&nbsp;<font color='green'>47.9%&nbsp;</font>YTD.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3394630\" data-linked=\"Lattice Semi closes +6.7% on price target boost\" data-tweet=\"$LSCC - Lattice Semi closes +6.7% on price target boost https://seekingalpha.com/news/3394630-lattice-semi-closesplus-6_7-on-price-target-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3394630-lattice-semi-closesplus-6_7-on-price-target-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394629\" data-ts=\"1538514272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NG\" target=\"_blank\">NG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394629-novagold-resources-beats-0_01\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NovaGold Resources beats by $0.01</a></h4><ul><li>NovaGold Resources (NYSEMKT:<a href='https://seekingalpha.com/symbol/NG' title='NovaGold Resources, Inc'>NG</a>): Q3 GAAP EPS of -$0.02 beats by $0.01.</li><li>Cash and term deposits of $165.96M</li><li>Shares&nbsp;<font color='green'>+1.85% post&nbsp;</font><font color='green'>market</font></li><li><a href=\"https://seekingalpha.com/pr/17288911-novagold-reports-third-quarter-results-donlin-gold-receives-record-decision-and-key-federal\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3394629\" data-linked=\"NovaGold Resources beats by $0.01\" data-tweet=\"$NG - NovaGold Resources beats by $0.01 https://seekingalpha.com/news/3394629-novagold-resources-beats-0_01?source=tweet\" data-url=\"https://seekingalpha.com/news/3394629-novagold-resources-beats-0_01\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394619\" data-ts=\"1538513205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGLY\" target=\"_blank\">DGLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394619-digital-allyminus-2-stockholders-file-to-sell-up-to-1_18m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Ally -2% as stockholders file to sell up to 1.18M shares</a></h4><ul>   <li>Digital Ally (NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>) is <font color='red'>off 2%</font> after hours, in light trading, after a <a href=\"https://seekingalpha.com/filing/4188986\" target=\"_blank\">registration statement</a> filing for sale by shareholders of up to 1.18M shares.</li>    <li>The shares are of common stock underlying various warrants.</li>    <li>Selling shareholders clearing out of their holdings include Brickell Key Investments, Global Equity Funding, Michael Doherty, Royal Roofing, WestPark Capital, Frank Salvatore, Doug Kaiser, Jonathon Bloom, and Brandon Ross. Another holder, Cory Royer, would still hold 47,139 shares (a 0.4% stake) after the offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3394619\" data-linked=\"Digital Ally -2% as stockholders file to sell up to 1.18M shares\" data-tweet=\"$DGLY - Digital Ally -2% as stockholders file to sell up to 1.18M shares https://seekingalpha.com/news/3394619-digital-allyminus-2-stockholders-file-to-sell-up-to-1_18m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3394619-digital-allyminus-2-stockholders-file-to-sell-up-to-1_18m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394608\" data-ts=\"1538512066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KALA\" target=\"_blank\">KALA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394608-kala-pharma-launches-7_5m-share-stock-offering-shares-down-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kala Pharma launches 7.5M-share stock offering; shares down 5% after hours</a></h4><ul><li>Kala Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/KALA' title='Kala Pharmaceuticals'>KALA</a>) slips&nbsp;<font color='red'>5%</font>&nbsp;after hours in reaction to its planned <a href=\"https://seekingalpha.com/pr/17288838-kala-pharmaceuticals-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> of 7.5M common shares. Underwriters over-allotment will be an additional 1.125M shares. Price and terms have yet to be released.</li><li>Separately, it has <a href=\"https://seekingalpha.com/pr/17288839-kala-pharmaceuticals-announces-financing-athyrium-capital-management-totaling-110-million\" target=\"_blank\">closed </a>a $110M credit facility with funds managed by Athyrium Capital Management, LP.</li><li>The company says it will use the capital to fund clinical trials and a U.S. marketing application for KPI-121 for dry eye disease by year-end and the launch of INVELTYS in early 2019. Topline data from a Phase 3 study of KPI-121 should be available this quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394608\" data-linked=\"Kala Pharma launches 7.5M-share stock offering; shares down 5% after hours\" data-tweet=\"$KALA - Kala Pharma launches 7.5M-share stock offering; shares down 5% after hours https://seekingalpha.com/news/3394608-kala-pharma-launches-7_5m-share-stock-offering-shares-down-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3394608-kala-pharma-launches-7_5m-share-stock-offering-shares-down-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394604\" data-ts=\"1538511738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIR\" target=\"_blank\">SIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394604-select-income-reit-dips-1_5-after-hours-after-starting-stock-offering-begins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select Income REIT dips 1.5% after-hours after starting stock offering begins</a></h4><ul><li>Select Income REIT (NYSE:<a href='https://seekingalpha.com/symbol/SIR' title='Select Income REIT'>SIR</a>)&nbsp;<font color='red'>drops 1.5%</font>&nbsp;in after-hours trading after Government Properties (NYSE:<a href='https://seekingalpha.com/symbol/GOV-OLD' title='Government Properties Income Trust'>GOV-OLD</a>)<a href=\"https://seekingalpha.com/pr/17288810-select-income-reit-announces-proposed-offering-24918-421-common-shares-owned-government\" target=\"_blank\"> starts a public offering</a> of 24.9M of SIR common shares.</li><li>The offering is part of Government Properties'&nbsp; plan to merge with Select Income. GOV will receive all net proceeds of the share sale and agreed to pay all costs associated with the offering.</li><li>Joint bookrunning managers for the offering are Citigroup, Bank of America Merrill Lynch, and Morgan Stanley. The joint lead managers are RBC Capital Markets and Wells Fargo Securities.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3390614-select-income-reit-jumps-merger-government-properties-income-trust\" target=\"_blank\">Select Income REIT jumps on merger with Government Properties Income Trust</a> (Sept. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394604\" data-linked=\"Select Income REIT dips 1.5% after-hours after starting stock offering begins\" data-tweet=\"$SIR $SIR $GOV-OLD - Select Income REIT dips 1.5% after-hours after starting stock offering begins https://seekingalpha.com/news/3394604-select-income-reit-dips-1_5-after-hours-after-starting-stock-offering-begins?source=tweet\" data-url=\"https://seekingalpha.com/news/3394604-select-income-reit-dips-1_5-after-hours-after-starting-stock-offering-begins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394598\" data-ts=\"1538511106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELGX\" target=\"_blank\">ELGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394598-endologix-sees-q3-revenue-high-34_7m-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endologix sees Q3 revenue as high as $34.7M; shares up 1% after hours</a></h4><ul><li>On a preliminary basis, Endologix (NASDAQ:<a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a>) <a href=\"https://seekingalpha.com/pr/17288767-endologix-announces-third-quarter-preliminary-revenue-results-raises-low-end-2018-revenue\" target=\"_blank\">expects Q3 revenue</a> of $34.3M - 34.7M. It also has raised the low end of its 2018 revenue guidance range $5M to $150M (upper limit of $155M).</li><li>The company is hosting an investor event this afternoon in New York.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;after hours.</li><li><strong>Update</strong>: Shares are up&nbsp;<font color='green'>37%&nbsp;</font>premarket on Wednesday, October 3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394598\" data-linked=\"Endologix sees Q3 revenue as high as $34.7M; shares up 1% after hours\" data-tweet=\"$ELGX - Endologix sees Q3 revenue as high as $34.7M; shares up 1% after hours https://seekingalpha.com/news/3394598-endologix-sees-q3-revenue-high-34_7m-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3394598-endologix-sees-q3-revenue-high-34_7m-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394597\" data-ts=\"1538511057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPX\" target=\"_blank\">TPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394597-tempur-sealy-jumps-on-report-of-imminent-mattress-firm-bankruptcy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tempur-Sealy jumps on report of imminent Mattress Firm bankruptcy</a></h4><ul><li>Tempur-Sealy International (NYSE:<a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a>) is&nbsp;<font color='green'>up 7%</font>&nbsp;in AH trading in a quick break higher following a Reuters report indicating that Mattress Firm could file for bankruptcy within a week.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394597\" data-linked=\"Tempur-Sealy jumps on report of imminent Mattress Firm bankruptcy\" data-tweet=\"$TPX - Tempur-Sealy jumps on report of imminent Mattress Firm bankruptcy https://seekingalpha.com/news/3394597-tempur-sealy-jumps-on-report-of-imminent-mattress-firm-bankruptcy?source=tweet\" data-url=\"https://seekingalpha.com/news/3394597-tempur-sealy-jumps-on-report-of-imminent-mattress-firm-bankruptcy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394593\" data-ts=\"1538510865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPZM\" target=\"_blank\">EPZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394593-epizyme-readies-stock-offering-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Epizyme readies stock offering; shares down 4% after hours</a></h4><ul><li>Epizyme (NASDAQ:<a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme'>EPZM</a>) slips&nbsp;<font color='red'>4%</font>&nbsp;after hours in reaction to its planned <a href=\"https://seekingalpha.com/pr/17288762-epizyme-announces-proposed-public-offering-common-stock\" target=\"_blank\">stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394593\" data-linked=\"Epizyme readies stock offering; shares down 4% after hours\" data-tweet=\"$EPZM - Epizyme readies stock offering; shares down 4% after hours https://seekingalpha.com/news/3394593-epizyme-readies-stock-offering-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3394593-epizyme-readies-stock-offering-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394587\" data-ts=\"1538509779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNJN\" target=\"_blank\">FNJN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394587-finjan-files-patent-infringement-claim-against-rapid7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finjan files patent infringement claim against Rapid7</a></h4><ul><li>        Finjan (NASDAQ:<a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a>)<a href=\"https://seekingalpha.com/pr/17288711-finjan-files-complaint-rapid7-inc-rapid7-llc-patent-infringement-district-court-delaware\" target=\"_blank\"> files</a> a patent infringement complaint against Rapid7 (NASDAQ:<a href='https://seekingalpha.com/symbol/RPD' title='Rapid7'>RPD</a>) for allegedly violating at least seven patents.</li><li>               Finjan says the filing with the U.S. District Court for the District of Delaware comes after &ldquo;more than two years of good faith efforts to resolve a patent dispute.&rdquo;&nbsp;</li><li>               The Rapid7 products involved in the complaint include the InsightIDR, InsightVM, InsightAppSec, AppSpider, Metasploit, and Komand tech.&nbsp;</li><li>               Finjan wants a jury trial, court costs, past damages not less than &ldquo;a reasonable royalty, and enhanced damages for &ldquo;willful, wanton and deliberate infringement.&rdquo;&nbsp;</li><li>               Finjan shares are&nbsp;<font color='red'>down 1%</font>&nbsp;to $4.35.&nbsp;</li><li>               Rapid7 shares are&nbsp;<font color='red'>down 0.03%</font>&nbsp;to $36.34.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3394587\" data-linked=\"Finjan files patent infringement claim against Rapid7\" data-tweet=\"$FNJN $FNJN $RPD - Finjan files patent infringement claim against Rapid7 https://seekingalpha.com/news/3394587-finjan-files-patent-infringement-claim-against-rapid7?source=tweet\" data-url=\"https://seekingalpha.com/news/3394587-finjan-files-patent-infringement-claim-against-rapid7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394586\" data-ts=\"1538509445\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394586-caesars-entertainment-higher-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caesars Entertainment higher after upgrade</a></h4><ul><li>Caesars Entertainment (<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a> <font color='green'>+1.4%</font>) pokes out a tidy gain after SunTrust Robinson Humphrey assumes coverage on the casino stock with a Buy rating.</li><li>Investors may also have their eyes on the latest report of gaming revenue out of Pennsylvania, which showed Caesers' Harrah's property gaining some market share against rivals.</li><li><a href=\"https://gamingcontrolboard.pa.gov/?p=196\" target=\"_blank\">PA Gaming Control Board data</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3394586\" data-linked=\"Caesars Entertainment higher after upgrade\" data-tweet=\"$CZR - Caesars Entertainment higher after upgrade https://seekingalpha.com/news/3394586-caesars-entertainment-higher-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3394586-caesars-entertainment-higher-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394583\" data-ts=\"1538508659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYN\" target=\"_blank\">SYN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394583-synthetic-bio-files-for-upsized-46m-equity-offering-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synthetic Bio files for upsized $46M equity offering; shares up 2%</a></h4><ul><li>Synthetic Biologics (<a href='https://seekingalpha.com/symbol/SYN' title='Synthetic Biologics, Inc.'>SYN</a> <font color='green'>+2.3%</font>) has filed an updated <a href=\"https://www.sec.gov/Archives/edgar/data/894158/000114420418052016/tv503858_s1a.htm\" target=\"_blank\">preliminary prospectus</a> for a $46M offering of Class A and Class B Units, up from $40M a couple of weeks ago (incorrectly reported as a $20M offering).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393761-synthetic-biologics-161-percent\" target=\"_blank\">Synthetic Biologics up 161%</a> (Sept. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394583\" data-linked=\"Synthetic Bio files for upsized $46M equity offering; shares up 2%\" data-tweet=\"$SYN - Synthetic Bio files for upsized $46M equity offering; shares up 2% https://seekingalpha.com/news/3394583-synthetic-bio-files-for-upsized-46m-equity-offering-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3394583-synthetic-bio-files-for-upsized-46m-equity-offering-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394578\" data-ts=\"1538507909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394578-gold-pushes-near-two-week-high-miners-sport-strong-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold pushes near two-week high, miners sport strong gains</a></h4><ul>     <li>Gold futures <a href=\"https://www.marketwatch.com/story/gold-finds-traction-amid-italy-ripples-even-as-dollar-gains-too-2018-10-02\" target=\"_blank\">settled back above $1,200/oz.</a> to reach their highest levels in nearly two weeks, boosted by jitters surrounding Italy&rsquo;s financial picture, lifting prices for the precious metal to their highest closing level in nearly two weeks.</li>     <li>December Comex gold settled <font color='green'>+1.3%</font> at $1,207/oz., after gold futures fell 4.6% in Q3 and slid 7.8% YTD.</li>     <li>&ldquo;The speed of today&rsquo;s rally in precious metals suggests rapid short-covering by hedge funds and other speculators who were betting against bullion,&rdquo; says Adrian Ash, director of research at BullionVault.</li>     <li>Gold&rsquo;s strength is &ldquo;impressive given the dollar is not weaker,&rdquo; says GoldCore's Mark O&rsquo;Byrne. &ldquo;Gold is very oversold and due a bounce.&rdquo;</li>     <li>Today's rally briefly positioned gold futures for a settlement above its 50-day moving average of $1,207.44/oz. for the <a href=\"https://seekingalpha.com/news/3394491-rare-rally-precious-metals\" target=\"_blank\">first time since April</a> before falling just short.</li>     <li>Gold mining shares are broadly higher: ABX <font color='green'>+4.7%</font>, <a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='green'>+2.8%</font>, <a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color='green'>+3.1%</font>, <a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a> <font color='green'>+3.2%</font>, <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='green'>+2.3%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color='green'>+4.6%</font>, <a href='https://seekingalpha.com/symbol/FNV' title='Franco-Nevada Corporation'>FNV</a> <font color='green'>+3.5%</font>, <a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color='green'>+2.6%</font>, <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color='green'>+4%</font>, <a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color='green'>+3.3%</font>, <a href='https://seekingalpha.com/symbol/RGLD' title='Royal Gold, Inc.'>RGLD</a> <font color='green'>+2.6%</font>, <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='green'>+5.1%</font>, <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='green'>+7.3%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a>, <a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/JDST' title='Direxion Daily Junior Gold Miners Index Bear 3x Shares ETF'>JDST</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='Aberdn Std Gold Shs'>SGOL</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/SGDJ' title='Sprott Junior Gold Miners ETF'>SGDJ</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/TGLDX' title='Tocqueville Gold Fund No Load'>TGLDX</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/PSAU' title='Invesco Global Gold and Precious Metals Portfolio ETF'>PSAU</a>, <a href='https://seekingalpha.com/symbol/GOAU' title='U.S. Global GO GOLD and Precious Metal Miners ETF'>GOAU</a>, <a href='https://seekingalpha.com/symbol/GDXX' title='ProShares Ultra Gold Miners ETF'>GDXX</a>, <a href='https://seekingalpha.com/symbol/GYEN' title='AdvisorShares Gartman Gold/Yen ETF'>GYEN</a>, <a href='https://seekingalpha.com/symbol/BAR' title='GraniteShares Gold Trust ETF'>BAR</a>, <a href='https://seekingalpha.com/symbol/GEUR' title='AdvisorShares Gartman Gold/Euro ETF'>GEUR</a>, <a href='https://seekingalpha.com/symbol/GDXS' title='ProShares UltraShort Gold Miners ETF'>GDXS</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a>, <a href='https://seekingalpha.com/symbol/GHS' title='REX Gold Hedged S&P 500 ETF'>GHS</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/QGLDX' title='The Gold Bullion Strategy Fund Inv'>QGLDX</a>, <a href='https://seekingalpha.com/symbol/GHE' title='REX Gold Hedged FTSE Emerging Markets ETF'>GHE</a>, <a href='https://seekingalpha.com/symbol/MELT' title='Direxion Daily Gold Miners Index Bear 1x Shares ETF'>MELT</a>, <a href='https://seekingalpha.com/symbol/AAAU' title='Perth Mint Physical Gold ETF'>AAAU</a>, <a href='https://seekingalpha.com/symbol/GLDM' title='World Gold Shares SPDR Gold Minishares Trust ETF'>GLDM</a>, <a href='https://seekingalpha.com/symbol/IAUF' title='iShares Gold Strategy ETF'>IAUF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3394578\" data-linked=\"Gold pushes near two-week high, miners sport strong gains\" data-tweet=\"$GOLD $GOLD $NEM - Gold pushes near two-week high, miners sport strong gains https://seekingalpha.com/news/3394578-gold-pushes-near-two-week-high-miners-sport-strong-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3394578-gold-pushes-near-two-week-high-miners-sport-strong-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394576\" data-ts=\"1538507434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394576-frontier-among-top-gainers-11-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier among top gainers with 11% move</a></h4><ul>   <li>Frontier Communications (NYSE:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) is among today's top-gaining stocks, <font color='green'>up 10.8%</font> on volume that's just slightly ahead of normal.</li>    <li>There's no apparent news as traders scratch for a reason for the move. Short percentage of float sat at 60.4% as of last month, while short percentage of shares outstanding was 29.3%.</li>    <li>Average volume has been lighter lately, while over the past quarter it's been about 3.2M shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3394576\" data-linked=\"Frontier among top gainers with 11% move\" data-tweet=\"$FTR - Frontier among top gainers with 11% move https://seekingalpha.com/news/3394576-frontier-among-top-gainers-11-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3394576-frontier-among-top-gainers-11-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394573\" data-ts=\"1538506518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394573-technology-top-5-gainers-losers-of-2_55-pm-10-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (10/02/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ATOM' title='Atomera Inc.'>ATOM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SYNC' title='Synacor'>SYNC</a> <font color='green'>+8%</font>.</li>     <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/NEON' title='Neonode, Inc.'>NEON</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='red'>-10%</font>.</li> &nbsp;     &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3394573\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (10/02/2018)\" data-tweet=\"$FTR $FTR $RUN - Technology - Top 5 Gainers / Losers as of 2.55 PM (10/02/2018) https://seekingalpha.com/news/3394573-technology-top-5-gainers-losers-of-2_55-pm-10-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3394573-technology-top-5-gainers-losers-of-2_55-pm-10-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394568\" data-ts=\"1538504495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDB\" target=\"_blank\">MDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394568-recent-tech-ipos-drop-after-mongodb-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Recent tech IPOs drop after MongoDB downgrade</a></h4><ul><li>           Newly public tech companies are feeling the pressure today in part due to Nomura&rsquo;s <a href=\"https://www.bloomberg.com/news/articles/2018-10-02/newly-public-tech-firms-face-reality-as-stock-runup-fades-away\" target=\"_blank\">downgrade</a> of MongoDB (<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a> <font color='red'>-3.9%</font>) from Reduce to Neutral. </li><li> Analyst Christopher Eberle says the company&rsquo;s &ldquo;current market value reflects extreme valuation.&rdquo; </li><li> Other movers: Zscaler (<a href='https://seekingalpha.com/symbol/ZS' title='Zscaler'>ZS</a> <font color='red'>-3.4%</font>), Carbon Black (<a href='https://seekingalpha.com/symbol/CBLK' title='Carbon Black'>CBLK</a> <font color='red'>-6.1%</font>), DocuSign (<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a> <font color='red'>-6.1%</font>), Arlo Technologies (<a href='https://seekingalpha.com/symbol/ARLO' title='Arlo Technologies'>ARLO</a> <font color='red'>-5.4%</font>), Zuora (<a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a> <font color='red'>-0.5%</font>). </li><li> Dropbox (<a href='https://seekingalpha.com/symbol/DBX' title='Dropbox'>DBX</a> <font color='green'>+1%</font>) is gaining after Nomura gave it an upgrade from Neutral to Reduce, per StreetAccount.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3394568\" data-linked=\"Recent tech IPOs drop after MongoDB downgrade\" data-tweet=\"$MDB $MDB $ZS - Recent tech IPOs drop after MongoDB downgrade https://seekingalpha.com/news/3394568-recent-tech-ipos-drop-after-mongodb-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3394568-recent-tech-ipos-drop-after-mongodb-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394562\" data-ts=\"1538503436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACET\" target=\"_blank\">ACET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394562-generics-in-green-following-proposed-favorable-guidance-from-fda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Generics in the green following proposed favorable guidance from FDA</a></h4><ul><li>Most generic drug firms are enjoying an uptick in buying. This morning, FDA Commissioner Scott Gottlieb, M.D., released a statement on preliminary guidance aimed at making the review process for generic drug applications more efficient.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a> <font color='green'>+4.9%</font>)(<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics'>ACRS</a> <font color='red'>-1.7%</font>)(<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color='green'>+3.2%</font>)(<a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar'>AMPH</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/ANIP' title='ANI Pharmaceuticals, Inc.'>ANIP</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a> <font color='red'>-0.4%</font>)(<a href='https://seekingalpha.com/symbol/COLL' title='Collegium Pharmaceutical'>COLL</a> <font color='green'>+0.4%</font>)(<a href='https://seekingalpha.com/symbol/EGRX' title='Eagle Pharmaceuticals Inc.'>EGRX</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='green'>+2.2%</font>)(<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc'>LCI</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt PLC'>MNK</a> <font color='green'>+2.6%</font>)(<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color='green'>+1.2%</font>)(<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='green'>+2.5%</font>)(<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color='green'>+0.5%</font>)(<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a> <font color='red'>-1.3%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3394479-fda-issues-new-draft-guidance-aimed-speedier-generic-approvals\" target=\"_blank\">FDA issues new draft guidance aimed at speedier generic approvals</a> (Oct. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394562\" data-linked=\"Generics in the green following proposed favorable guidance from FDA\" data-tweet=\"$ACET $ACET $ACRS - Generics in the green following proposed favorable guidance from FDA https://seekingalpha.com/news/3394562-generics-in-green-following-proposed-favorable-guidance-from-fda?source=tweet\" data-url=\"https://seekingalpha.com/news/3394562-generics-in-green-following-proposed-favorable-guidance-from-fda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394560\" data-ts=\"1538503317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IGC\" target=\"_blank\">IGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394560-energy-materials-top-5-gainers-losers-of-2-00-pm-10-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials  - Top 5 Gainers / Losers as of 2:00 PM (10/02/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/UAN' title='CVR Partners, LP'>UAN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PRT' title='PermRock Royalty Trust'>PRT</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderurgica Nacional'>SID</a>&nbsp;<font color='green'>+7%</font></li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/REI' title='Ring Energy, Inc.'>REI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NGVT' title='Ingevity Corporation'>NGVT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394560\" data-linked=\"Energy/Materials  - Top 5 Gainers / Losers as of 2:00 PM (10/02/2018)\" data-tweet=\"$IGC $IGC $PBR - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (10/02/2018) https://seekingalpha.com/news/3394560-energy-materials-top-5-gainers-losers-of-2-00-pm-10-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3394560-energy-materials-top-5-gainers-losers-of-2-00-pm-10-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394556\" data-ts=\"1538501699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOO\" target=\"_blank\">SHOO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394556-apparel-sector-bid-down-on-mix-of-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apparel sector bid down on mix of news</a></h4><ul><li>Apparel stocks trade weak on the day on a mix of news seen as potentially troublesome for the sector. Filtering in today are a downgrade on Steven Madden (<a href='https://seekingalpha.com/symbol/SHOO' title='Steven Madden, Ltd.'>SHOO</a> <font color='red'>-3.7%</font>) from Wedbush on tariff concerns, weak guidance from Stitch Fix (<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a> <font color='red'>-32.6%</font>)&nbsp;and the potential for labor inflation across the sector after Amazon hiked its minimum wage.</li><li>Decliners include Vera Bradley (<a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a> <font color='red'>-4.8%</font>), Crocs (<a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a> <font color='red'>-4.2%</font>), Fossil (<a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='red'>-2.9%</font>), Deckers Outdoor (<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='green'>+0.9%</font>), Foot Locker (<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='red'>-3.3%</font>), Wolverine World Wide (<a href='https://seekingalpha.com/symbol/WWW' title='Wolverine World Wide Inc.'>WWW</a> <font color='red'>-2.6%</font>), Caleres (<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='red'>-2.1%</font>) and Rocky Brands (<a href='https://seekingalpha.com/symbol/RCKY' title='Rocky Brands, Inc.'>RCKY</a> <font color='red'>-2.3%</font>), Vince Holdings (<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='red'>-5.9%</font>), G-III Apparel (<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='red'>-5.6%</font>), Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='red'>-2%</font>), Kohl's (<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a> <font color='red'>-2.1%</font>), Under Armour (<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a> <font color='red'>-3.9%</font>), Michael Kors (KORS <font color='red'>-2.5%</font>), Canada Goose (<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='red'>-2.6%</font>), Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='red'>-3.2%</font>), Nordstrom (<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> <font color='red'>-2.2%</font>) and Ralph Lauren (<a href='https://seekingalpha.com/symbol/RL' title='Ralph Lauren Corporation'>RL</a> <font color='red'>-2.7%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3394556\" data-linked=\"Apparel sector bid down on mix of news\" data-tweet=\"$SHOO $SHOO $SFIX - Apparel sector bid down on mix of news https://seekingalpha.com/news/3394556-apparel-sector-bid-down-on-mix-of-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3394556-apparel-sector-bid-down-on-mix-of-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394554\" data-ts=\"1538501333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394554-infineraplus-3_2-morgan-stanley-hopeful-on-centurylink-decision\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinera +3.2% with Morgan Stanley hopeful on CenturyLink decision</a></h4><ul>   <li>Infinera (<a href=\"http://seekingalpha.com/symbol/INFN\" target=\"_blank\">INFN</a> <font color='green'>+3.2%</font>) is higher today amid another analyst's hopeful take on the fate of its relationship with key customer CenturyLink.</li>    <li>Shares spiked this afternoon to a gain of as much as 6.1% before settling back to its solid steady 3.2% gain.</li>    <li>Yesterday's debate centered on MKM's take that Infinera would <a href=\"https://seekingalpha.com/news/3393966-infinera-minus-13_7-percent-analyst-predicts-major-customer-loss\" target=\"_blank\">lose CenturyLink as a customer</a> to a rival like Ciena (<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a> <font color='green'>+0.6%</font>); Infinera <a href=\"https://seekingalpha.com/news/3394187-infinera-takes-issue-mkm-report-dilution-customer-loss\" target=\"_blank\">pushed back against that report</a> with a statement later that said CenturyLink hadn't made a final decision on the matter.</li>    <li>Now Morgan Stanley's Meta Marshall says that while losing CenturyLink wouldn't be a positive, the company's statement holds out opportunity through the end of the year. The firm's keeping Infinera at the top of its Optical Scorecard, and says its bull case has Infinera gaining share to reach a $20 price based on EPS of $1.50-$2.00, while the share-losing bear case has Infinera at $4. (h/t Bloomberg)</li>    <li>Marshall's base-case target is $9.50 (EPS of $0.75-$1.00).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3394554\" data-linked=\"Infinera +3.2% with Morgan Stanley hopeful on CenturyLink decision\" data-tweet=\"$CIEN $CIEN $INFN - Infinera +3.2% with Morgan Stanley hopeful on CenturyLink decision https://seekingalpha.com/news/3394554-infineraplus-3_2-morgan-stanley-hopeful-on-centurylink-decision?source=tweet\" data-url=\"https://seekingalpha.com/news/3394554-infineraplus-3_2-morgan-stanley-hopeful-on-centurylink-decision\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394548\" data-ts=\"1538500331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTVT\" target=\"_blank\">VTVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394548-vtv-therapeutics-up-122\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vtv Therapeutics up 122%</a></h4><ul><li>Thinly traded nano cap vTv Therapeutics (<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='green'>+121.6%</font>) rockets on a whopping 121x surge in volume.</li><li>The company just filed an <a href=\"https://www.sec.gov/Archives/edgar/data/1641489/000156459018023807/vtvt-8k_20180927.htm\" target=\"_blank\">8-K</a> disclosing that top investor MacAndrews &amp; Forbes Group, controlled by noted investor Ronald Perelman, just bought another 1,879,699 Class A common shares at $1.33 per share pursuant to a July 30 agreement. Its stake is now over 36M shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394548\" data-linked=\"Vtv Therapeutics up 122%\" data-tweet=\"$VTVT - Vtv Therapeutics up 122% https://seekingalpha.com/news/3394548-vtv-therapeutics-up-122?source=tweet\" data-url=\"https://seekingalpha.com/news/3394548-vtv-therapeutics-up-122\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394641\" data-ts=\"1538500111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGVT\" target=\"_blank\">NGVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394641-ingevityminus-8-berenberg-downgrades-to-hold-from-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ingevity -8% as Berenberg downgrades to Hold from Buy</a></h4><ul>     <li>Shares of specialty chemicals manufacturer Ingevity (<a href='https://seekingalpha.com/symbol/NGVT' title='Ingevity Corporation'>NGVT</a> <font color='red'>-7.9%</font>) tumble nearly 8% after Berenberg <a href=\"https://thefly.com/thestreet/realmoney/index.php/NGVTid2798223/NGVT-Ingevity-downgraded-to-Hold-from-Buy-at-Berenberg\" target=\"_blank\">downgrades</a> to Hold from Buy with a $110 price target, trimmed from $115, on valuation after rising 47% YTD.</li><li>Berenberg's Paretosh Misra says the spot price weakness in fatty acids and gum rosin commodities may hurt pricing in parts of NGVT's performance chemicals business.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394641\" data-linked=\"Ingevity -8% as Berenberg downgrades to Hold from Buy\" data-tweet=\"$NGVT - Ingevity -8% as Berenberg downgrades to Hold from Buy https://seekingalpha.com/news/3394641-ingevityminus-8-berenberg-downgrades-to-hold-from-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3394641-ingevityminus-8-berenberg-downgrades-to-hold-from-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394542\" data-ts=\"1538499673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATLC\" target=\"_blank\">ATLC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394542-financials-top-5-gainers-losers-of-1-00-pm-10-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (10/02/2018)</a></h4><ul><li><b>Gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/ATLC' title='Atlanticus Holdings Corp.'>ATLC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='green'>+8%</font>.</li><li><b>Losers: </b><a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394542\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (10/02/2018)\" data-tweet=\"$ATLC $ATLC $BSBR - Financials - Top 5 Gainers / Losers as of 1:00 PM (10/02/2018) https://seekingalpha.com/news/3394542-financials-top-5-gainers-losers-of-1-00-pm-10-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3394542-financials-top-5-gainers-losers-of-1-00-pm-10-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394537\" data-ts=\"1538499037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGM\" target=\"_blank\">NGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394537-nash-players-under-pressure-following-liver-meeting-abstract-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NASH players under pressure following Liver Meeting abstract drop</a></h4><ul><li>Biotechs developing treatments for nonalcoholic steatohepatitis &#40;NASH&#41; and other fatty liver diseases are seeing some action following the release of abstracts for November's Liver Meeting in San Francisco.</li><li>Raymond James' Steven Seedhouse says the weakness in ENTA and ICPT is due to weak FXR agonist data from GILD.</li><li>A new NASH player is looming IPO NGM Biopharmaceuticals (<a href='https://seekingalpha.com/symbol/NGM' title='NGM Biopharmaceuticals'>NGM</a>) with lead candidate NGM282.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='red'>-4.6%</font>)(<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='green'>+1%</font>)(<a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='red'>-2.4%</font>)(<a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a> <font color='red'>-5.2%</font>)(<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='red'>-5.4%</font>)(<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a>)(<a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color='red'>-3.3%</font>)(<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-3.2%</font>)(<a href='https://seekingalpha.com/symbol/GNFTF' title='Genfit'>OTCPK:GNFTF</a> <font color='red'>-4.2%</font>)(<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='green'>+2.7%</font>)(<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a> <font color='red'>-1.2%</font>)(<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='red'>-1.6%</font>)(<a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a>)(<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+4.7%</font>)(<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a> <font color='red'>-3.9%</font>)(<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a> <font color='red'>-2.4%</font>)(<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='green'>+0.8%</font>)(<a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='green'>+2.4%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+0.7%</font>)(<a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color='green'>+1.2%</font>)(<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/ARCT' title='Arcturus Therapeutics Ltd.'>ARCT</a>)(<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color='red'>-4.4%</font>)(<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen'>FGEN</a> <font color='green'>+1.1%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393889-ngm-biopharmaceuticals-deck-ipo\" target=\"_blank\">NGM Biopharmaceuticals on deck for IPO</a> (Oct. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394537\" data-linked=\"NASH players under pressure following Liver Meeting abstract drop\" data-tweet=\"$NGM $NGM $VKTX - NASH players under pressure following Liver Meeting abstract drop https://seekingalpha.com/news/3394537-nash-players-under-pressure-following-liver-meeting-abstract-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3394537-nash-players-under-pressure-following-liver-meeting-abstract-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394536\" data-ts=\"1538498656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394536-midday-gainers-losers-10-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (10/02/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+92%</font>. <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='green'>+62%</font>. <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+58%</font>. <a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='green'>+49%</font>. <a href='https://seekingalpha.com/symbol/IMTE' title='Integrated Media Technology Limited'>IMTE</a> <font color='green'>+43%</font>. <a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/SYN' title='Synthetic Biologics, Inc.'>SYN</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+18%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/ABIO' title='ARCA biopharma, Inc.'>ABIO</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/REI' title='Ring Energy, Inc.'>REI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/MESO' title='Mesoblast'>MESO</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ADRO' title='Aduro Biotech'>ADRO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AVRO' title='AVROBIO'>AVRO</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='red'>-12%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3394536\" data-linked=\"Midday Gainers / Losers (10/02/2018)\" data-tweet=\"$OGEN $OGEN $DTEA - Midday Gainers / Losers (10/02/2018) https://seekingalpha.com/news/3394536-midday-gainers-losers-10-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3394536-midday-gainers-losers-10-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394535\" data-ts=\"1538498512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EA\" target=\"_blank\">EA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394535-report-slowdown-for-fortnite-may-be-just-in-time-for-ea-activision\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Slowdown for &#39;Fortnite&#39; may be just in time for EA, Activision</a></h4><ul>   <li>There may be some good news for videogame giants wrestling with the craze for Epic Games' battle-royale hit <i>Fortnite,</i> as M Science's TickerTags sees a turn in social media signaling a slowdown.</li>    <li>Twitter mentions (an indicator of daily payers and bookings) are declining for the first time on a season launch day, TickerTags says -- 37% lower than for season 5, 29% lower than season 4 and 13% lower than for season 3.</li>    <li>That coincides with key holiday releases introducing their own battle royale modes in response: Blackout in <i>Call of Duty: Black Ops 4</i> (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color='green'>+0.4%</font>), and <i>Firestorm</i> in Battlefield V (NASDAQ:<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>).</li>    <li>Tencent (<a href=\"http://seekingalpha.com/symbol/TCEHY\" target=\"_blank\">TCEHY</a> <font color='red'>-2%</font>) owns 40% of Epic.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3394535\" data-linked=\"Report: Slowdown for &#39;Fortnite&#39; may be just in time for EA, Activision\" data-tweet=\"$EA $EA $ATVI - Report: Slowdown for &#39;Fortnite&#39; may be just in time for EA, Activision https://seekingalpha.com/news/3394535-report-slowdown-for-fortnite-may-be-just-in-time-for-ea-activision?source=tweet\" data-url=\"https://seekingalpha.com/news/3394535-report-slowdown-for-fortnite-may-be-just-in-time-for-ea-activision\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394534\" data-ts=\"1538498478\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOBC\" target=\"_blank\">AOBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394534-firearms-stocks-track-lower-for-second-consecutive-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Firearms stocks track lower for second consecutive day</a></h4><ul><li>Firearms-related stocks are down again as the impact of federal action on a bump-stocks accessory ban is assessed by investors.</li><li>Yesterday, President Trump said preparations for the ban were in their final stages.</li><li>Tracking lower in mid-day trading are American Outdoor Brands (<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='red'>-1.2%</font>), Sturm, Ruger (<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a> <font color='red'>-1.1%</font>), Vista Outdoors (<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a> <font color='red'>-1.3%</font>) and Sportsman's Warehouse (<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='red'>-2.3%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3394534\" data-linked=\"Firearms stocks track lower for second consecutive day\" data-tweet=\"$AOBC $AOBC $RGR - Firearms stocks track lower for second consecutive day https://seekingalpha.com/news/3394534-firearms-stocks-track-lower-for-second-consecutive-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3394534-firearms-stocks-track-lower-for-second-consecutive-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394533\" data-ts=\"1538498406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394533-semi-stocks-trade-up-catalysts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semi stocks trade up with few catalysts</a></h4><ul><li>Semiconductor stocks are on the move heading into the afternoon without a load of associated catalysts.</li><li>Gainers include Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+3.1%</font>), Analog Devices (<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a> <font color='green'>+1.3%</font>), Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>+5%</font>) and Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='green'>+2.4%</font>), which are potentially rebounding after yesterday&rsquo;s analyst cuts. Intel could also make an appearance at today's Microsoft fall event.</li><li>More gainers: (<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a> <font color='green'>+2.4%</font>), (<a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings'>SGH</a> <font color='green'>+4%</font>), (<a href='https://seekingalpha.com/symbol/UCTT' title='Ultra Clean Holdings, Inc.'>UCTT</a> <font color='green'>+1.4%</font>), (<a href='https://seekingalpha.com/symbol/AMKR' title='Amkor Technology, Inc.'>AMKR</a> <font color='green'>+2%</font>), (<a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='green'>+1.7%</font>), (<a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='green'>+1.5%</font>), (<a href='https://seekingalpha.com/symbol/SMTC' title='Semtech Corporation'>SMTC</a> <font color='green'>+1.2%</font>), (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='green'>+1.5%</font>), (<a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a> <font color='green'>+1.4%</font>), (<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a> <font color='green'>+1.1%</font>), (<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a> <font color='green'>+1.5%</font>), (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color='green'>+2.2%</font>).</li><li>AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-3.4%</font>) is heading in the opposite direction possibly because of yesterday&rsquo;s launch of Google&rsquo;s Project Stream in-browser gaming test program. But the company also had an analyst downgrade yesterday and dropped last Friday as rival Intel updated its 10nm chip supply.</li><li>The Philadelphia Semiconductor Index is currently&nbsp;<font color='green'>up 1.2%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3394509-microsoft-reveal-new-surface-models-today\" target=\"_blank\">Microsoft could reveal new Surface models today</a> (Oct. 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393776-amd-minus-4_5-percent-intels-10nm-supply-update\" target=\"_blank\">AMD -4.5% on Intel's 10nm supply update</a> (Sept. 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3394017-deutsche-mizuho-throw-towel-semi-nand-stocks\" target=\"_blank\">Deutsche and Mizuho throw in towel on semi, NAND stocks</a> (Oct. 1)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393958-intel-amd-drop-analysts-cut-expectations\" target=\"_blank\">Intel, AMD drop as analysts cut expectations</a> (Oct. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394533\" data-linked=\"Semi stocks trade up with few catalysts\" data-tweet=\"$MU $MU $ADI - Semi stocks trade up with few catalysts https://seekingalpha.com/news/3394533-semi-stocks-trade-up-catalysts?source=tweet\" data-url=\"https://seekingalpha.com/news/3394533-semi-stocks-trade-up-catalysts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>118&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394532\" data-ts=\"1538498118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REI\" target=\"_blank\">REI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394532-ring-energyminus-18-after-seaport-cuts-shares-to-neutral-from-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ring Energy -18% after Seaport cuts shares to Neutral from Buy</a></h4><ul>     <li>Ring Energy (<a href='https://seekingalpha.com/symbol/REI' title='Ring Energy, Inc.'>REI</a> <font color='red'>-17.5%</font>) plunges to a 52-week low after Seaport Global <a href=\"https://thefly.com/thestreet/realmoney/index.php/REIid2798282/REI-Ring-Energy-downgraded-to-Neutral-from-Buy-at-Seaport-Global\" target=\"_blank\">downgrades</a> shares to Neutral from Buy with a $12 price target, cut from $20.</li>     <li>Seaport analyst John Aschenbeck says he reviewed state data obtained from DrillingInfo and concluded that REI's 2018 San Andres completions have been underperforming older vintages by ~25% and his prior type curve estimates by 34%.</li>     <li>Shares already have tumbled by more than 50% since early May, and has suffered <a href=\"https://www.zacks.com/stock/news/325408/weakness-seen-in-ring-energy-rei-estimates-should-you-stay-away\" target=\"_blank\">six downward Q3 EPS estimate revisions</a> over 60 days, dragging the consensus estimate down to $0.13 from $0.16.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394532\" data-linked=\"Ring Energy -18% after Seaport cuts shares to Neutral from Buy\" data-tweet=\"$REI - Ring Energy -18% after Seaport cuts shares to Neutral from Buy https://seekingalpha.com/news/3394532-ring-energyminus-18-after-seaport-cuts-shares-to-neutral-from-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3394532-ring-energyminus-18-after-seaport-cuts-shares-to-neutral-from-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394530\" data-ts=\"1538497080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNC\" target=\"_blank\">SYNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394530-synacorplus-6-after-corporate-update-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synacor +6% after corporate update presentation</a></h4><ul><li>        Synacor (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNC' title='Synacor'>SYNC</a>) continues to gain from yesterday&rsquo;s corporate presentation highlighting its cloud-based software business and growth strategies.</li><li>               The details include an update to Syancor&rsquo;s recurring-revenue software business, blockchain enhancements to the Zimbra collaboration platform, and cost-reduction plans.&nbsp;</li><li>               See the presentation slides <a href=\"https://seekingalpha.com/filing/4185370\" target=\"_blank\">here</a>.&nbsp;</li><li>               Synacor shares are&nbsp;<font color='green'>up 6.1%&nbsp;</font>to $2.03.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3394530\" data-linked=\"Synacor +6% after corporate update presentation\" data-tweet=\"$SYNC - Synacor +6% after corporate update presentation https://seekingalpha.com/news/3394530-synacorplus-6-after-corporate-update-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3394530-synacorplus-6-after-corporate-update-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394521\" data-ts=\"1538496757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IGC\" target=\"_blank\">IGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394521-india-globalization-capital-gift-short-citron\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">India Globalization Capital a &quot;gift&quot; short - Citron</a></h4><ul><li>\"If you are able to short, it is a gift,\" <a href=\"https://twitter.com/CitronResearch/status/1047156337287688192\" target=\"_blank\">tweets Andrew Left</a>.</li><li>\"No product. All hype. Raised Money 2 weeks ago at $1.15&nbsp; Finger traders will get burned. This hype stock is the poster child of a cannabis bubble. Always cautious but nothing but air. Could write pages about this scheme.\"</li><li>India Globalization Capital (<a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a>) is&nbsp;<font color='green'>up 43%</font>&nbsp;today to $12.89.</li><li><strong>Update at 12: 35 ET: </strong>Citron <a href=\"https://twitter.com/CitronResearch/status/1047158872450850816\" target=\"_blank\">makes a correction</a>, noting IGC has raised capital three times in three weeks at an average price of $3.31. \"Stock should have a skull and crossbones at Fidelity ... Target price - $6 fast.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3394521\" data-linked=\"India Globalization Capital a &quot;gift&quot; short - Citron\" data-tweet=\"$IGC - India Globalization Capital a &quot;gift&quot; short - Citron https://seekingalpha.com/news/3394521-india-globalization-capital-gift-short-citron?source=tweet\" data-url=\"https://seekingalpha.com/news/3394521-india-globalization-capital-gift-short-citron\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394515\" data-ts=\"1538496042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTEA\" target=\"_blank\">DTEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394515-consumer-top-5-gainers-losers-of-12-00-pm-10-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (10/02/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LW' title='Lamb Weston Holdings, Inc.'>LW</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/VNE' title='Veoneer, Inc.'>VNE</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394515\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (10/02/2018)\" data-tweet=\"$DTEA $DTEA $KNDI - Consumer - Top 5 Gainers / Losers as of 12:00 PM (10/02/2018) https://seekingalpha.com/news/3394515-consumer-top-5-gainers-losers-of-12-00-pm-10-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3394515-consumer-top-5-gainers-losers-of-12-00-pm-10-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394507\" data-ts=\"1538494860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MO\" target=\"_blank\">MO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394507-altria-on-watch-after-fda-seizes-juul-documents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altria on watch after FDA seizes Juul documents</a></h4><ul> <li>Altria (<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color='green'>+0.8%</font>) breaks higher after CNBC reports on a surprise inspection of Juul by the FDA that included the \"seizing\" of more than a thousand documents.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3394507\" data-linked=\"Altria on watch after FDA seizes Juul documents\" data-tweet=\"$MO - Altria on watch after FDA seizes Juul documents https://seekingalpha.com/news/3394507-altria-on-watch-after-fda-seizes-juul-documents?source=tweet\" data-url=\"https://seekingalpha.com/news/3394507-altria-on-watch-after-fda-seizes-juul-documents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394491\" data-ts=\"1538492895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394491-rare-rally-for-precious-metals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rare rally for precious metals</a></h4><ul><li>Gold today is&nbsp;<font color='green'>ahead 1.4%</font>&nbsp;to $1,209 per ounce, while silver is&nbsp;<font color='green'>up 2.8%&nbsp;</font>to $14.92.</li><li>Bloomberg notes gold has moved above its 50-day moving average - the metal hasn't closed above that metric since April.</li><li>Possibly behind the buying is the continued slow-motion meltdown in Italy, where stocks are&nbsp;<font color='red'>down another 1.2%</font>, and the yield on the country's 10-year paper is higher by 10.5 basis points to 3.412%. That's nearly a full 200 basis point higher than Spain, and less than 100 basis points behind the yield on Greek 10-years.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3394301-euro-weakens-italian-political-risk\" target=\"_blank\">Euro weakens on Italian political risk</a> (Oct. 2)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/SLV' title='iShares Silver Trust ETF'>SLV</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/AGQ' title='ProShares Ultra Silver ETF'>AGQ</a>, <a href='https://seekingalpha.com/symbol/PSLV' title='Sprott Physical Silver Trust'>PSLV</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/USLV' title='VelocityShares 3x Long Silver ETN'>USLV</a>, <a href='https://seekingalpha.com/symbol/SIVR' title='Aberd Std Silvr Shs'>SIVR</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='Aberdn Std Gold Shs'>SGOL</a>, <a href='https://seekingalpha.com/symbol/ZSL' title='ProShares UltraShort Silver ETF'>ZSL</a>, <a href='https://seekingalpha.com/symbol/SLVO' title='Credit Suisse Silver Shares Covered Call ETN'>SLVO</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/DSLV' title='VelocityShares 3x Inverse Silver ETN'>DSLV</a>, <a href='https://seekingalpha.com/symbol/DBS' title='Invesco DB Silver ETF'>DBS</a>, <a href='https://seekingalpha.com/symbol/GYEN' title='AdvisorShares Gartman Gold/Yen ETF'>GYEN</a>, <a href='https://seekingalpha.com/symbol/BAR' title='GraniteShares Gold Trust ETF'>BAR</a>, <a href='https://seekingalpha.com/symbol/GEUR' title='AdvisorShares Gartman Gold/Euro ETF'>GEUR</a>, <a href='https://seekingalpha.com/symbol/GHS' title='REX Gold Hedged S&P 500 ETF'>GHS</a>, <a href='https://seekingalpha.com/symbol/USV' title='UBS ETRACS CMCI Silver Total Return ETN'>USV</a>, <a href='https://seekingalpha.com/symbol/SHNY' title='Direxion Daily Silver Miners Index Bull 2x Shares ETF'>SHNY</a>, <a href='https://seekingalpha.com/symbol/QGLDX' title='The Gold Bullion Strategy Fund Inv'>QGLDX</a>, <a href='https://seekingalpha.com/symbol/GHE' title='REX Gold Hedged FTSE Emerging Markets ETF'>GHE</a>, <a href='https://seekingalpha.com/symbol/DULL' title='Direxion Daily Silver Miners Index Bear 2x Shares ETF'>DULL</a>, <a href='https://seekingalpha.com/symbol/AAAU' title='Perth Mint Physical Gold ETF'>AAAU</a>, <a href='https://seekingalpha.com/symbol/GLDM' title='World Gold Shares SPDR Gold Minishares Trust ETF'>GLDM</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3394491\" data-linked=\"Rare rally for precious metals\" data-tweet=\"$GLD $SLV $IAU - Rare rally for precious metals https://seekingalpha.com/news/3394491-rare-rally-for-precious-metals?source=tweet\" data-url=\"https://seekingalpha.com/news/3394491-rare-rally-for-precious-metals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394487\" data-ts=\"1538492591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XENT\" target=\"_blank\">XENT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394487-intersect-ent-up-4-on-anthem-coverage-of-sinuva-implant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intersect ENT up 4% on Anthem coverage of Sinuva implant</a></h4><ul><li>Thinly traded Intersect ENT (<a href='https://seekingalpha.com/symbol/XENT' title='Intersect ENT'>XENT</a> <font color='green'>+4%</font>) is up on average volume on the heels of Anthem's <a href=\"https://fm.formularynavigator.com/FBO/143/National_4_Tier_ABCBS.pdf\" target=\"_blank\">coverage </a>of its Sinuva (mometasone furoate) Sinus implant for the treatment of nasal polyps.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317499-fda-oks-intersect-ents-sinuva-sinus-implant-shares-17-percent\" target=\"_blank\">FDA OKs Intersect ENT's Sinuva sinus implant; shares up 17%</a> (Dec. 11, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394487\" data-linked=\"Intersect ENT up 4% on Anthem coverage of Sinuva implant\" data-tweet=\"$XENT - Intersect ENT up 4% on Anthem coverage of Sinuva implant https://seekingalpha.com/news/3394487-intersect-ent-up-4-on-anthem-coverage-of-sinuva-implant?source=tweet\" data-url=\"https://seekingalpha.com/news/3394487-intersect-ent-up-4-on-anthem-coverage-of-sinuva-implant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394484\" data-ts=\"1538492491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394484-healthcare-top-5-gainers-losers-of-11-00-10-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/02/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+83%</font>. <a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CTXR' title='Citius Pharmaceuticals Inc.'>CTXR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ABIO' title='ARCA biopharma, Inc.'>ABIO</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/MTNB' title='Matinas Biopharma Holdings, Inc.'>MTNB</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MESO' title='Mesoblast'>MESO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ADRO' title='Aduro Biotech'>ADRO</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394484\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/02/2018)\" data-tweet=\"$OGEN $OGEN $ATRS - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/02/2018) https://seekingalpha.com/news/3394484-healthcare-top-5-gainers-losers-of-11-00-10-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3394484-healthcare-top-5-gainers-losers-of-11-00-10-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394483\" data-ts=\"1538492368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NNDM\" target=\"_blank\">NNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394483-nano-dimensionplus-5_6-on-doubling-armed-forces-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nano Dimension +5.6% on doubling its Armed Forces sales</a></h4><ul><li>        Nano Dimension (NASDAQ:<a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a>) <a href=\"https://seekingalpha.com/pr/17287178-nano-dimension-strengthens-position-defense-sector-selling-two-additional-additive\" target=\"_blank\">announces</a> the sale of two additional DragonFly Pro precision additive manufacturing systems to different branches of the U.S. Armed Forces.</li><li>               The new sale brings the total number of Armed Forces customers to four since the company received a commercial and government entity code from the Department of Defense in June.&nbsp;</li><li>               NNDM shares are<font color='green'> up 5.6%</font>&nbsp;to $2.03.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3394483\" data-linked=\"Nano Dimension +5.6% on doubling its Armed Forces sales\" data-tweet=\"$NNDM - Nano Dimension +5.6% on doubling its Armed Forces sales https://seekingalpha.com/news/3394483-nano-dimensionplus-5_6-on-doubling-armed-forces-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3394483-nano-dimensionplus-5_6-on-doubling-armed-forces-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394476\" data-ts=\"1538491775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APDN\" target=\"_blank\">APDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394476-applied-dna-sciencesplus-11-on-securing-rna-therapeutic-customers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied DNA Sciences +11% on securing RNA therapeutic customers</a></h4><ul><li>        Applied DNA Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a>) continues to gain on yesterday&rsquo;s <a href=\"https://seekingalpha.com/pr/17285386-linearx-secures-new-rna-therapeutics-customers-contract-research-services\" target=\"_blank\">announcement</a> that subsidiary LineaRx secured multiple new developers of RNA therapeutics as customers for its contract research organization services.</li><li>               Terms weren&rsquo;t disclosed.&nbsp;</li><li>               APDN shares are&nbsp;<font color='green'>up 11%</font>&nbsp;to $1.56.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3394476\" data-linked=\"Applied DNA Sciences +11% on securing RNA therapeutic customers\" data-tweet=\"$APDN - Applied DNA Sciences +11% on securing RNA therapeutic customers https://seekingalpha.com/news/3394476-applied-dna-sciencesplus-11-on-securing-rna-therapeutic-customers?source=tweet\" data-url=\"https://seekingalpha.com/news/3394476-applied-dna-sciencesplus-11-on-securing-rna-therapeutic-customers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394473\" data-ts=\"1538491675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEP\" target=\"_blank\">PEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394473-pepsico-dips-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PepsiCo dips after earnings</a></h4><ul> <li>PepsiCo (<a href='https://seekingalpha.com/symbol/PEP' title='PepsiCo Inc.'>PEP</a> <font color='red'>-1%</font>) trades slightly lower after releasing earnings this morning.</li> <li>Analysts note that the company topped estimates through the help of a lower effective tax rate, but that underlying margins weren't as strong as anticipated.</li> <li>On the conference call (<a href=\"http://www.pepsico.com/Investors/Events-and-Presentations\" target=\"_blank\">webcast</a>), PepsiCo management reminded that its beverage price increases weren't in effect until September and (as expected) says it's sitting out the cannabis craze at least until federal regulations become clearer.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3394314-pepsico-beats-0_02-beats-revenue\" target=\"_blank\">PepsiCo beats by $0.02, beats on revenue</a> (Oct. 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3394323-pepsico-beats-q3-estimates-revised-fy2018-guidance\" target=\"_blank\">PepsiCo beats Q3 estimates, revised FY2018 guidance</a> (Oct. 2)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3394473\" data-linked=\"PepsiCo dips after earnings\" data-tweet=\"$PEP - PepsiCo dips after earnings https://seekingalpha.com/news/3394473-pepsico-dips-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3394473-pepsico-dips-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394466\" data-ts=\"1538491306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATOM\" target=\"_blank\">ATOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394466-atomera-pops-11_5-on-license-deal-stmicroelectronics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atomera pops 11.5% on license deal with STMicroelectronics</a></h4><ul><li>           Atomera (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOM' title='Atomera Inc.'>ATOM</a>) <a href=\"https://seekingalpha.com/pr/17287970-atomera-licenses-mst-stmicroelectronics\" target=\"_blank\">announces</a> that STMicroelectronics (NYSE:<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a>) has signed an integration license for Atomera&rsquo;s Mears Silicon Technology &#40;MST&#41;, which enhances transistors. </li><li> The license gives ST certain rights to integrate the MST tech into their products and will serve as the first of a three-phase process. The next two licensing phases will involve manufacturing and distribution. </li><li> Financial terms weren&rsquo;t disclosed. </li><li> Atomera shares are&nbsp;<font color='green'>up 11.5%</font>&nbsp;to $6.13. </li><li> STMicroelectronics shares are&nbsp;<font color='green'>up 2.8%</font>&nbsp;to $18.79. &nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3394466\" data-linked=\"Atomera pops 11.5% on license deal with STMicroelectronics\" data-tweet=\"$ATOM $ATOM $STM - Atomera pops 11.5% on license deal with STMicroelectronics https://seekingalpha.com/news/3394466-atomera-pops-11_5-on-license-deal-stmicroelectronics?source=tweet\" data-url=\"https://seekingalpha.com/news/3394466-atomera-pops-11_5-on-license-deal-stmicroelectronics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394462\" data-ts=\"1538491024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LW\" target=\"_blank\">LW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394462-lamb-weston-rallies-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lamb Weston rallies after earnings</a></h4><ul><li>Lamb Weston (NYSE:<a href='https://seekingalpha.com/symbol/LW' title='Lamb Weston Holdings, Inc.'>LW</a>) is&nbsp;<font color='green'>up 5.9%</font>&nbsp;after turning in a Q2 earnings report that topped consensus estimates. Analysts are pointing to Lamb Weston's combination of volume and price/mix gains as a positive sign.</li><li>The company also reaffirmed its FQ1 and FY19 guidance.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3394452-lamb-weston-q1-results\" target=\"_blank\">More on Lamb Weston Q1 results</a> (Oct. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394462\" data-linked=\"Lamb Weston rallies after earnings\" data-tweet=\"$LW - Lamb Weston rallies after earnings https://seekingalpha.com/news/3394462-lamb-weston-rallies-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3394462-lamb-weston-rallies-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394459\" data-ts=\"1538490651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLNX\" target=\"_blank\">MLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394459-jefferies-sees-50-upside-to-mellanox\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies sees 50% upside to Mellanox</a></h4><ul><li>        Mellanox Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNX' title='Mellanox Technologies, Ltd.'>MLNX</a>)&nbsp;<font color='green'>gains 4%&nbsp;</font>after Jefferies initiates the company at Buy with a $110 price target, a 50% upside to yesterday&rsquo;s close.</li><li>Source: StreetAccount.</li><li>               MLNX is&nbsp;<font color='red'>down 10%</font>&nbsp;in the past month,&nbsp;<font color='red'>15%</font>&nbsp;in the quarter, but gained&nbsp;<font color='green'>13.5%</font>&nbsp;YTD and<font color='green'> 55.8%</font>&nbsp;in the past year.&nbsp;</li><li>               Mellanox is expected to report earnings on October 24.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3370828-mellanox-tech-plus-1_5-percent-q2-beats-upside-q3-fy-guide\" target=\"_blank\">Mellanox Tech +1.5% on Q2 beats, upside Q3 and FY guide</a> (July 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394459\" data-linked=\"Jefferies sees 50% upside to Mellanox\" data-tweet=\"$MLNX - Jefferies sees 50% upside to Mellanox https://seekingalpha.com/news/3394459-jefferies-sees-50-upside-to-mellanox?source=tweet\" data-url=\"https://seekingalpha.com/news/3394459-jefferies-sees-50-upside-to-mellanox\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394448\" data-ts=\"1538489334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394448-moodys-places-ge-credit-rating-under-review-for-possible-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moody&#39;s places GE credit rating under review for possible downgrade</a></h4><ul>     <li>General Electric's (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-2.6%</font>) A2 credit rating is <a href=\"https://www.cnbc.com/2018/10/02/ge-credit-rating-under-review-for-possible-downgrade-moodys.html\" target=\"_blank\">under review for a possible downgrade</a> at Moody's, which cites GE's announcement that it will fall short of its 2018 earnings and free cash  flow guidance amid weak performance from its power business.</li>     <li>\"Among the range of issues that Moody's will consider is the impact on  GE's earnings and cash flow prospects of the continuing deterioration in  its Power business, which is likely to persist for some time,\" Moody's says.</li>     <li>\"The dimmer prospects for GE Power take on heightened  importance given the loss of free cash flow from GE's planned  divestitures, including the highly cash generative GE Transportation and  GE Healthcare,\" according to the ratings agency.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394448\" data-linked=\"Moody&#39;s places GE credit rating under review for possible downgrade\" data-tweet=\"$GE - Moody&#39;s places GE credit rating under review for possible downgrade https://seekingalpha.com/news/3394448-moodys-places-ge-credit-rating-under-review-for-possible-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3394448-moodys-places-ge-credit-rating-under-review-for-possible-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394443\" data-ts=\"1538489142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWE\" target=\"_blank\">WWE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394443-wweminus-2_2-tv-exec-sells-1_8m-in-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WWE -2.2% as TV exec sells $1.8M in shares</a></h4><ul>   <li>World Wrestling Entertainment (<a href=\"http://seekingalpha.com/symbol/WWE\" target=\"_blank\">WWE</a> <font color='red'>-2.2%</font>) is lower this morning alongside an exec's insider sales in the stock.</li>    <li>Kevin Dunn, chief of Global Television Production, sold 15,509 shares at an average of $96.70 and 3,599 shares at $97.36, for <a href=\"https://seekingalpha.com/filing/4186466\" target=\"_blank\">aggregate proceeds</a> of just over $1.85M.</li>    <li>Meanwhile, directors Stuart Goldfarb, Patricia Gottesman, Robyn Peterson, Frank Riddick, Jeffrey Speed and Laureen Ong acquired 265 shares each at no cost.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3394443\" data-linked=\"WWE -2.2% as TV exec sells $1.8M in shares\" data-tweet=\"$WWE - WWE -2.2% as TV exec sells $1.8M in shares https://seekingalpha.com/news/3394443-wweminus-2_2-tv-exec-sells-1_8m-in-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3394443-wweminus-2_2-tv-exec-sells-1_8m-in-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394440\" data-ts=\"1538488923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOL\" target=\"_blank\">GOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394440-latin-american-airline-stocks-gain-on-brazil-election-relief\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Latin American airline stocks gain on Brazil election relief</a></h4><ul> <li>A nice rally in the Brazilian stock market due to political polling viewed as favorable has some Latin American airline stocks traded in the U.S. also moving higher.</li> <li>Gainers include GOL Linhas (<a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas Areas Inteligentes S.A.'>GOL</a> <font color='green'>+7.8%</font>), LATAM Airlines (<a href='https://seekingalpha.com/symbol/LTM' title='LATAM Airlines Group S.A.'>LTM</a> <font color='green'>+3.5%</font>), Azul (<a href='https://seekingalpha.com/symbol/AZUL' title='Azul'>AZUL</a> <font color='green'>+4.9%</font>), Copa Holdings (<a href='https://seekingalpha.com/symbol/CPA' title='Copa Holdings, S.A.'>CPA</a> <font color='green'>+1.6%</font>) and Volaris (<a href='https://seekingalpha.com/symbol/VLRS' title='Volaris Aviation'>VLRS</a> <font color='green'>+1.4%</font>).</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3394440\" data-linked=\"Latin American airline stocks gain on Brazil election relief\" data-tweet=\"$GOL $GOL $LTM - Latin American airline stocks gain on Brazil election relief https://seekingalpha.com/news/3394440-latin-american-airline-stocks-gain-on-brazil-election-relief?source=tweet\" data-url=\"https://seekingalpha.com/news/3394440-latin-american-airline-stocks-gain-on-brazil-election-relief\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394437\" data-ts=\"1538488607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEVB\" target=\"_blank\">LEVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394437-level-brandsplus-20-on-cannabis-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Level Brands +20% on more cannabis buzz</a></h4><ul> <li>Level Brands (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEVB' title='Level Brands, Inc.'>LEVB</a>) is <font color='green'>up 20%</font> in early trading to extend on yesterday's rally. The company is being pulled into the investor excitement over cannabis-infused beverages.</li> <li>Shares of Level Brands traded at an all-time high of $7.39 just minutes ago. The company's Regulation A IPO was priced at $6.00 per share last year.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3394437\" data-linked=\"Level Brands +20% on more cannabis buzz\" data-tweet=\"$LEVB $YCBD - Level Brands +20% on more cannabis buzz https://seekingalpha.com/news/3394437-level-brandsplus-20-on-cannabis-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/3394437-level-brandsplus-20-on-cannabis-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394428\" data-ts=\"1538487563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEGGF\" target=\"_blank\">MEGGF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394428-meggitt-awarded-multi-year-agreement-u-s-defense-logistics-agency\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meggitt awarded multi-year agreement with U.S. Defense Logistics Agency</a></h4><ul>     <li>Meggitt Plc (<a href='https://seekingalpha.com/symbol/MEGGF' title='Meggitt Plc'>OTCPK:MEGGF</a>) has been <a href=\"http://otp.investis.com/clients/uk/meggitt_plc1/rns_teaser/regulatory-story.aspx?cid=420&amp;newsid=1194574\" target=\"_blank\">awarded</a> a five year Indefinite Demand/Indefinite Quantity agreement with the U.S. Defense Logistics Agency to supply wheels, brakes and related spare parts.</li>     <li>The contract, worth $323M over the life of the award, covers the supply of depot-level spares for a number of defence platforms including F-16 Falcon, H-60 Blackhawk and CH-47 Chinook.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3394428\" data-linked=\"Meggitt awarded multi-year agreement with U.S. Defense Logistics Agency\" data-tweet=\"$MEGGF - Meggitt awarded multi-year agreement with U.S. Defense Logistics Agency https://seekingalpha.com/news/3394428-meggitt-awarded-multi-year-agreement-u-s-defense-logistics-agency?source=tweet\" data-url=\"https://seekingalpha.com/news/3394428-meggitt-awarded-multi-year-agreement-u-s-defense-logistics-agency\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394418\" data-ts=\"1538486613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTEA\" target=\"_blank\">DTEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394418-premarket-gainers-of-9-05-10-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (10/02/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='green'>+39%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3394376-davidstea-bid-51-percent-speculative-move\" target=\"_blank\">speculative move</a>.</li><li><a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+36%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3394406-cellectar-bio-clr-131-shows-positive-action-early-stage-multiple-myeloma-study-shares-ahead\" target=\"_blank\">showing</a> positive action in early-stage multiple myeloma study.</li><li><a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+26%</font>.</li><li><a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='green'>+23%</font>.</li><li><a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+16%</font>.</li><li><a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a> <font color='green'>+14%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17287624-china-recycling-energy-corp-announces-acquisition-20-percent-equity-interest-xi-xinhuan\" target=\"_blank\">acquisition</a> of 20% of the equity interests of Xi&rsquo;an Xinhuan Energy.</li><li><a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+13%</font>.</li><li><a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3394377-clovis-oncology-receives-breakthrough-therapy-designation-rubraca\" target=\"_blank\">receiving</a> Breakthrough Therapy designation for Rubraca.</li><li><a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17287178-nano-dimension-strengthens-position-defense-sector-selling-two-additional-additive\" target=\"_blank\">selling</a> two additional DragonFly Pro systems to different branches of the United States Armed Forces.</li><li><a href='https://seekingalpha.com/symbol/LEVB' title='Level Brands, Inc.'>LEVB</a> <font color='green'>+7%</font>. as US cannabis market <a href=\"https://seekingalpha.com/pr/17288006-research-projects-u-s-medical-cannabis-market-reach-usd-12_5-billion-2025\" target=\"_blank\">expected</a> to reach $12.5B by 2025.</li><li><a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a> <font color='green'>+9%</font>.</li><li><a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3394357-premarket-analyst-action-healthcare\" target=\"_blank\">positive</a> analyst action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394418\" data-linked=\"Premarket Gainers as of 9:05 am (10/02/2018)\" data-tweet=\"$DTEA $DTEA $CLRB - Premarket Gainers as of 9:05 am (10/02/2018) https://seekingalpha.com/news/3394418-premarket-gainers-of-9-05-10-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3394418-premarket-gainers-of-9-05-10-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394397\" data-ts=\"1538486126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNN\" target=\"_blank\">RNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394397-rexahn-pharmas-rxminus-3117-shows-positive-action-in-mid-stage-pancreatic-cancer-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rexahn Pharma&#39;s RX-3117 shows positive action in mid-stage pancreatic cancer study; shares up 4% premarket</a></h4><ul><li>Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a>) is up<font color=\"green\">4%</font>premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17287528-rexahn-pharmaceuticals-presents-preliminary-safety-efficacy-data-ongoing-phase-2a-clinical\" target=\"_blank\">announcement </a>of preliminary data from its Phase 2a clinical trial evaluating RX-3117, combined with Celgene's Abraxane (nab-paclitaxel), for the first-line treatment of patients with pancreatic cancer. The results were presented at the NCI Pancreatic Cancer Symposium in Bethesda, MD.</li><li>The disease control rate (responders + those with stable cancer) was 86% (n=12/14), including one complete responder (after six cycles of therapy) and three partial responders (two after two cycles of treatment and the other after four cycles). The overall response rate was 29% (n=4/14).</li><li>Final data should be available in 2019.</li><li>RX-3117 is an orally available small molecule nucleoside compound. Once activated by an enzyme called UCK2, it is incorporated into cancer cells where it induces cell death by inhibiting DNA and RNA synthesis. UCK2 is overexpressed in a range of cancer cells.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330194-rexahns-rxminus-3117-shows-positive-effect-mid-stage-bladder-cancer-study\" target=\"_blank\">Rexahn's RX-3117 shows positive effect in mid-stage bladder cancer study</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394397\" data-linked=\"Rexahn Pharma&#39;s RX-3117 shows positive action in mid-stage pancreatic cancer study; shares up 4% premarket\" data-tweet=\"$RNN $REXN - Rexahn Pharma&#39;s RX-3117 shows positive action in mid-stage pancreatic cancer study; shares up 4% premarket https://seekingalpha.com/news/3394397-rexahn-pharmas-rxminus-3117-shows-positive-action-in-mid-stage-pancreatic-cancer-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3394397-rexahn-pharmas-rxminus-3117-shows-positive-action-in-mid-stage-pancreatic-cancer-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394410\" data-ts=\"1538485756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABIO\" target=\"_blank\">ABIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394410-premarket-losers-of-9-05-10-2-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (10/2/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/ABIO' title='ARCA biopharma, Inc.'>ABIO</a> <font color='red'>-22%</font>.</li><li><a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>&nbsp;<font color='red'>-21%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3394231-stitch-fix-beats-0_13-revenue-line\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>&nbsp;<font color='red'>-12%</font>.</li><li><a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='red'>-11%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17286979-acasti-pharma-announces-issuance-common-shares-payment-outstanding-interest-debentures\" target=\"_blank\">issuing</a> common shares in payment of outstanding interest under debentures.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3394410\" data-linked=\"Premarket Losers as of 9:05 am (10/2/2018)\" data-tweet=\"$ABIO $ABIO $SFIX - Premarket Losers as of 9:05 am (10/2/2018) https://seekingalpha.com/news/3394410-premarket-losers-of-9-05-10-2-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3394410-premarket-losers-of-9-05-10-2-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394408\" data-ts=\"1538485518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394408-stitch-fix-falls-back-to-earth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stitch Fix falls back to earth</a></h4><ul> <li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) is <font color='red'>down 20%</font> in premarket trading after the online retailer posted earnings and new guidance yesterday after the closing bell.</li> <li>Analysts attribute the outsized downward move in shares more to a pulling back on valuation after an extended months-long rally than disappointing results.</li> <li>During the Stitch Fix conference call (<a href=\"https://seekingalpha.com/article/4209251-stitch-fix-inc-sfix-ceo-katrina-lake-q4-2018-results-earnings-call-transcript\" target=\"_blank\">transcript</a>), CEO Katrina Lake highlighted that the company recorded its highest quarterly gross margin in FY18 and topped last year's FQ4 mark by 90 bps. \"This improvement was driven by a decrease in inventory reserve, lower clearance expense and reductions in shrink, all reflections of our initiatives to strengthen our operations and inventory management, \"she noted.</li><li>Analyst price target changes on SFIX: Goldman Sachs to $40 from $24, SunTrust to $40 from $38, Piper Jaffray to $31 from $43, Piper Jaffray to $31 from $43.</li><li>Stitch Fix is still up 75% YTD.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3394231-stitch-fix-beats-0_13-revenue-line\" target=\"_blank\">Stitch Fix beats by $0.13,  revenue in-line</a> (Oct. 1)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3394240-post-earnings-decline-stitch-fix\" target=\"_blank\">Post-earnings decline for Stitch Fix</a> (Oct. 1)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3394408\" data-linked=\"Stitch Fix falls back to earth\" data-tweet=\"$SFIX - Stitch Fix falls back to earth https://seekingalpha.com/news/3394408-stitch-fix-falls-back-to-earth?source=tweet\" data-url=\"https://seekingalpha.com/news/3394408-stitch-fix-falls-back-to-earth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394406\" data-ts=\"1538485416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394406-cellectar-bio-clr-131-shows-positive-action-in-early-stage-multiple-myeloma-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar Bio CLR 131 shows positive action in early-stage multiple myeloma study; shares ahead 43% premarket</a></h4><ul><li>Thinly traded nano cap Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) is up&nbsp;<font color='green'>43%</font>&nbsp;premarket on robust volume on the heels of its <a href=\"https://seekingalpha.com/pr/17287560-cellectar-announces-overall-survival-exceeding-19-months-phase-1b-trial-clr-131-relapsed\" target=\"_blank\">announcement </a>of positive interim data from its ongoing Phase 1b clinical trial evaluating CRL 131 in patients with relapsed/refractory multiple myeloma &#40;MM&#41;.</li><li>Updated results showed overall survival &#40;OS&#41; at 19.4 months in heavily pretreated MM patients. All had received an average of five previous lines of multidrug therapy.</li><li>A Phase 2 MM study is in process.</li><li>CLR 131 is a phospholipid ether-drug conjugate &#40;PDC&#41; that selectively delivers radiation to malignant cancer cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394406\" data-linked=\"Cellectar Bio CLR 131 shows positive action in early-stage multiple myeloma study; shares ahead 43% premarket\" data-tweet=\"$CLRB - Cellectar Bio CLR 131 shows positive action in early-stage multiple myeloma study; shares ahead 43% premarket https://seekingalpha.com/news/3394406-cellectar-bio-clr-131-shows-positive-action-in-early-stage-multiple-myeloma-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3394406-cellectar-bio-clr-131-shows-positive-action-in-early-stage-multiple-myeloma-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394398\" data-ts=\"1538484789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTK\" target=\"_blank\">PRTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394398-fda-oks-parateks-sarecycline-for-acne\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Paratek&#39;s sarecycline for acne</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17287836-fda-approves-seysara-sarecycline-treatment-moderate-severe-acne\" target=\"_blank\">approves </a>Paratek Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a>) SEYSARA (sarecycline) for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients at least nine years old.</li><li>Allergan (NYSE:<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>), owner of exclusive development and commercialization rights for acne in the U.S., has assigned the rights to Almirall SA (<a href='https://seekingalpha.com/symbol/LBTSF' title='Almirall SA'>OTC:LBTSF</a>). Paratek retains all ex-U.S. rights.</li><li>PRTK is up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394398\" data-linked=\"FDA OKs Paratek&#39;s sarecycline for acne\" data-tweet=\"$PRTK $PRTK $AGN - FDA OKs Paratek&#39;s sarecycline for acne https://seekingalpha.com/news/3394398-fda-oks-parateks-sarecycline-for-acne?source=tweet\" data-url=\"https://seekingalpha.com/news/3394398-fda-oks-parateks-sarecycline-for-acne\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394392\" data-ts=\"1538483912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394392-deutsche-bank-sees-heightened-risks-for-facebook-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank sees heightened risks for Facebook into 2019</a></h4><ul><li>        Deutsche Bank out cautious on Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) after the first day of Advertising Week, where the firm held meetings with industry executives.</li><li>               Deutsche sees heightened risk to Street estimates in Q3, Q4, and 2019 due to mixed channel feedback.&nbsp;</li><li>               Facebook&rsquo;s platform ad revenue for clients looks to have decelerated in Q3 particularly at the end of the quarter. Risks to Q4 include slow client execution in prepping for the end of third-party partner data.&nbsp;</li><li>        Source: <a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">Notable Calls</a>.&nbsp;                   </li><li>               Facebook shares are&nbsp;<font color='red'>down 0.7%</font>&nbsp;premarket to $161.30.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3394392\" data-linked=\"Deutsche Bank sees heightened risks for Facebook into 2019\" data-tweet=\"$FB - Deutsche Bank sees heightened risks for Facebook into 2019 https://seekingalpha.com/news/3394392-deutsche-bank-sees-heightened-risks-for-facebook-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3394392-deutsche-bank-sees-heightened-risks-for-facebook-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394390\" data-ts=\"1538483717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQ\" target=\"_blank\">SQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394390-square-gets-big-price-target-boost-from-keybanc-analyst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Square gets big price target boost from KeyBanc analyst</a></h4><ul><li>Square (NYSE:<a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a>)&nbsp;<font color='green'>gains 1.1%</font>&nbsp;in premarket trading after KeyBanc's Josh Beck boosts his price target on the stock 53% to $115 from $75, making it the second-highest on Wall Street, according to Bloomberg.</li><li>His old price target, though, was 23% under Square's closing price of $97.28 on Monday. <a href=\"https://seekingalpha.com/symbol/SQ/earnings/analyst_ratings\" target=\"_blank\">Average analyst price target</a> for Square stands at $77.72.</li><li>Beck notes that sellers plan to increase the number of non-payment products they plan to adopt. According to a KeyBanc survey of 20 sellers,&nbsp; respondents on average expect to use 3.4 non-payment products, including such applications as invoices, loans, marketing, payroll, in the next year, up 106% from now.</li><li>Also from the survey, about 70% of sellers didn't consider a competitor when choosing Square.</li><li><a href=\"https://seekingalpha.com/symbol/SQ/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a> for Square:15 strong buys, 18 holds, 1 underperform, and 3 sells.</li><li>Source: Bloomberg First Word.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3392707-square-plus-2_3-percent-two-bullish-analyst-reports\" target=\"_blank\">Square +2.3% after two bullish analyst reports</a> (Sept. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394390\" data-linked=\"Square gets big price target boost from KeyBanc analyst\" data-tweet=\"$SQ - Square gets big price target boost from KeyBanc analyst https://seekingalpha.com/news/3394390-square-gets-big-price-target-boost-from-keybanc-analyst?source=tweet\" data-url=\"https://seekingalpha.com/news/3394390-square-gets-big-price-target-boost-from-keybanc-analyst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394389\" data-ts=\"1538483661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LW\" target=\"_blank\">LW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394389-lamb-weston-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lamb Weston beats by $0.05, beats on revenue</a></h4><ul><li>Lamb Weston (NYSE:<a href='https://seekingalpha.com/symbol/LW' title='Lamb Weston Holdings, Inc.'>LW</a>): Q1 Non-GAAP EPS of $0.73 <span style=\"color:green\">beats by $0.05</span>; GAAP EPS of $0.73.</li><li>Revenue of $914.9M (+11.9% Y/Y) <font color='green'>beats by $34.8M</font>.</li><li>Shares <font color='green'>+1.68%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17287727-lamb-weston-reports-fiscal-first-quarter-2019-results-reaffirms-fiscal-year-2019-outlook'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3394389\" data-linked=\"Lamb Weston beats by $0.05, beats on revenue\" data-tweet=\"$LW - Lamb Weston beats by $0.05, beats on revenue https://seekingalpha.com/news/3394389-lamb-weston-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3394389-lamb-weston-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394387\" data-ts=\"1538483566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394387-arena-pharmas-ralinepag-shows-durable-treatment-effect-in-mid-stage-pah-extension-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena Pharma&#39;s ralinepag shows durable treatment effect in mid-stage PAH extension study; shares up 1% premarket</a></h4><ul><li>Arena Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;premarket, albeit on only 100 shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17287565-arena-pharmaceuticals-reports-positive-long-term-data-ongoing-open-label-extension-phase-2\" target=\"_blank\">announcement </a>of positive long-term data from an open-label extension of a Phase 2 clinical trial evaluating ralinepag, a prostacyclin receptor agonist, in patients with pulmonary arterial hypertension &#40;PAH&#41;.</li><li>Patients who continued on ralinepag had a median duration of treatment of 1.8 years at the time of right heart catheterization. They showed sustained improvements from baseline <a href=\"https://www.nursingcenter.com/ncblog/may-2017/systemic-vascular-resistance-and-pulmonary-vascula\" target=\"_blank\">pulmonary vascular resistance</a> &#40;PVR&#41; (a measure of the extent that pulmonary circulation \"resists\" cardiac output) and 6-minute walk test distance. The separation from control was statistically significant.</li><li>Patients switching from placebo to ralinepag (median duration of treatment = 1.4 years) experienced similar statistically valid sustained treatment benefits.</li><li>Most of the patients were already receiving dual combination PAH background therapy.</li><li>No new safety signals were observed.</li><li>Ralinepag is currently in Phase 3 development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394387\" data-linked=\"Arena Pharma&#39;s ralinepag shows durable treatment effect in mid-stage PAH extension study; shares up 1% premarket\" data-tweet=\"$ARNA - Arena Pharma&#39;s ralinepag shows durable treatment effect in mid-stage PAH extension study; shares up 1% premarket https://seekingalpha.com/news/3394387-arena-pharmas-ralinepag-shows-durable-treatment-effect-in-mid-stage-pah-extension-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3394387-arena-pharmas-ralinepag-shows-durable-treatment-effect-in-mid-stage-pah-extension-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394383\" data-ts=\"1538483080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVIV\" target=\"_blank\">NVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394383-invivo-therapeutics-up-8-on-collaborating-privately-held-q-therapeutics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InVivo Therapeutics up 8% on collaborating with privately held Q Therapeutics</a></h4><ul> <li>InVivo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a>) has       <a href=\"https://seekingalpha.com/pr/17287474-invivo-therapeutics-announces-joint-research-collaboration-q-therapeutics-inc\" target=\"_blank\">entered</a> into a joint research agreement with Q Therapeutics, a       privately held developer of clinical-stage cell therapies for central       nervous system &#40;CNS&#41; disease and injury.</li>          <li>The research collaboration is focused on the evaluation of the       combination of InVivo&rsquo;s proprietary PLGA-PLL based Neuro-Spinal       Scaffold with Q Therapeutics&rsquo; adult neural progenitor cells,       including those from induced pluripotent stem cells (iPSCs).</li><li>Financial terms are not disclosed.</li><li>NVIV shares are up&nbsp;<font color='green'>8%</font>&nbsp;premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3394383\" data-linked=\"InVivo Therapeutics up 8% on collaborating with privately held Q Therapeutics\" data-tweet=\"$NVIV - InVivo Therapeutics up 8% on collaborating with privately held Q Therapeutics https://seekingalpha.com/news/3394383-invivo-therapeutics-up-8-on-collaborating-privately-held-q-therapeutics?source=tweet\" data-url=\"https://seekingalpha.com/news/3394383-invivo-therapeutics-up-8-on-collaborating-privately-held-q-therapeutics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394381\" data-ts=\"1538482931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394381-new-age-beveragesminus-15-on-huge-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages -15% on huge volume</a></h4><ul> <li>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) looks like it's setting up for another volatile day.</li> <li>NBEV is <font color='red'>down 14.88%</font> in premarket action on volume of over 1.9M shares.</li> <li>There isn't any specific news out on New Age amid the ongoing cannabis speculation. Earlier today, PepsiCo's earnings report came and went without any M&amp;A hints.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3394381\" data-linked=\"New Age Beverages -15% on huge volume\" data-tweet=\"$NBEV - New Age Beverages -15% on huge volume https://seekingalpha.com/news/3394381-new-age-beveragesminus-15-on-huge-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3394381-new-age-beveragesminus-15-on-huge-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394379\" data-ts=\"1538482586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394379-u-s-steel-downgraded-deutsche-bank-offers-cautious-steel-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel downgraded as Deutsche Bank offers more cautious steel outlook</a></h4><ul>     <li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color='red'>-2.1%</font> pre-market as Deutsche Bank <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Deutsche+Bank+Downgrades+US+Steel+%28X%29+to+Hold/14663232.html\" target=\"_blank\">downgrades</a> shares to Hold from Buy with a $35 price target, cut from $47, saying its outlook for the industry is moderating as peak pricing for steels has played out.</li><li>Mini mills have a more flexible cost base, more exposure to long products and better capital return potential, Deutsche Bank's Chris Terry says.</li><li>The firm also downgrades Reliance Steel (NYSE:<a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a>) to Hold from Buy but maintains Buy ratings on Commercial Metals (NYSE:<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a>), Nucor (NYSE:<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>) and Steel Dynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>) due to more favorable risk/reward balance.</li><li>ETF: <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3394379\" data-linked=\"U.S. Steel downgraded as Deutsche Bank offers more cautious steel outlook\" data-tweet=\"$X $X $RS - U.S. Steel downgraded as Deutsche Bank offers more cautious steel outlook https://seekingalpha.com/news/3394379-u-s-steel-downgraded-deutsche-bank-offers-cautious-steel-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3394379-u-s-steel-downgraded-deutsche-bank-offers-cautious-steel-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394377\" data-ts=\"1538482570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLVS\" target=\"_blank\">CLVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394377-clovis-oncology-receives-breakthrough-therapy-designation-for-rubraca\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clovis Oncology receives Breakthrough Therapy designation for Rubraca</a></h4><ul> <li>The FDA&nbsp;<a href=\"https://seekingalpha.com/pr/17287466-clovis-oncology-receives-breakthrough-therapy-designation-rubraca-rucaparib-treatment-brca1-2\" target=\"_blank\">grants</a> Breakthrough Therapy designation&nbsp;for Clovis Oncology's (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a>) Rubraca (rucaparib) as a monotherapy       treatment of adult patients with BRCA1/2-mutated mCRPC who have received       at least one prior androgen receptor &#40;AR&#41;-directed therapy and       taxane-based chemotherapy.</li>     <li>Breakthrough Therapy status provides for more intensive guidance from the FDA on development, the involvement of more senior agency personnel and a rolling review of the marketing application.</li><li>Breakthrough Therapy designation is granted to Rubraca based on initial data from ongoing TRITON2 Phase 2 study in advanced prostate cancer.</li><li>Shares are up&nbsp;<font color='green'>8%</font>&nbsp;premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3394377\" data-linked=\"Clovis Oncology receives Breakthrough Therapy designation for Rubraca\" data-tweet=\"$CLVS - Clovis Oncology receives Breakthrough Therapy designation for Rubraca https://seekingalpha.com/news/3394377-clovis-oncology-receives-breakthrough-therapy-designation-for-rubraca?source=tweet\" data-url=\"https://seekingalpha.com/news/3394377-clovis-oncology-receives-breakthrough-therapy-designation-for-rubraca\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394376\" data-ts=\"1538482563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTEA\" target=\"_blank\">DTEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394376-davidstea-bid-up-51-in-speculative-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DavidsTea bid up 51% in speculative move</a></h4><ul> <li>DavidsTea (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a>) is <font color='green'>up 45%</font> in premarket trading as the volatile trading continues for the beverage stock amid broad cannabis speculation.</li> <li>DavidTea interim CEO Herschel Segal was fairly firm last week that the company wasn't quite ready for a cannabis partnership.</li><li>Volume on DavidsTea in the premarket session is over 508K shares.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393673-davidstea-plus-9-percent-cannabis-frenzy-continues\" target=\"_blank\">DavidsTea +9% as cannabis frenzy continues</a> (Sept. 28)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3394376\" data-linked=\"DavidsTea bid up 51% in speculative move\" data-tweet=\"$DTEA - DavidsTea bid up 51% in speculative move https://seekingalpha.com/news/3394376-davidstea-bid-up-51-in-speculative-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3394376-davidstea-bid-up-51-in-speculative-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394357\" data-ts=\"1538479809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYE\" target=\"_blank\">EYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394357-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>National Vision (NASDAQ:<a href='https://seekingalpha.com/symbol/EYE' title='National Vision Holdings'>EYE</a>) initiated with Equal Weight rating and $50 (12% upside) price target at Barclays.</li><li>Inovio Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a>) resumed with Buy rating and $8 (50% upside) price target at Stifel.</li><li>Theratechnologies (<a href='https://seekingalpha.com/symbol/THERF' title='Theratechnologies Inc.'>OTCPK:THERF</a>) (TH.TO) upgraded to Buy with a C$15 (72% upside) price target at Canaccord Genuity.</li><li>Edward Lifesciences (NYSE:<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a>) downgraded to Neutral at Guggenheim. Shares down&nbsp;<font color='red'>3%</font>&nbsp;premarket.</li><li>Geron (NASDAQ:<a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a>) downgraded to Neutral with a $1.50 (flat) price target at B. Riley FBR. Shares down&nbsp;<font color='red'>4%</font>&nbsp;premarket.</li><li>Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a>) downgraded to Outperform with a $141 ( 11% upside) price target at Raymond James.</li><li>Akorn (NASDAQ:<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a>) price target cut to $5 (flat) from $34 at Piper Jaffray and to $10 from $27 at RBC following Fresenius court win allowing it to nix troubled merger. Shares up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3394357\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$EYE $EYE $INO - Premarket analyst action - healthcare https://seekingalpha.com/news/3394357-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3394357-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3394323\" data-ts=\"1538475791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEP\" target=\"_blank\">PEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3394323-pepsico-beats-q3-estimates-revised-fy2018-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PepsiCo beats Q3 estimates, revised FY2018 guidance</a></h4><ul><li>PepsiCo (NYSE:<a href='https://seekingalpha.com/symbol/PEP' title='PepsiCo Inc.'>PEP</a>) reports organic revenue growth of 4.9% in <a href=\"https://seekingalpha.com/pr/17287284-pepsico-reports-third-quarter-2018-results\" target=\"_blank\">Q3</a>.</li><li>Foreign exchange translation negtively impacted revenue by 2%.</li><li>Revenue by segment: Frito-Lay North America: $3.89B (+3%); Quaker Foods North America: $567M (-2%); Latin America: $1.87B (flat);&nbsp;North America Beverages: $5.46B (+2%);&nbsp;Europe Sub-Saharan Africa: $3.16B (+2%); AMEA: $1.54B (-2%).</li><li>Asia, Middle East and North Africa core operating profit&nbsp;grew 18% to $313M.</li><li>Total core gross margin slipped 10 bps to 54.5%.</li><li>Total core operating margin down 30 bps to 17.6%.</li><li><b>FY2018 Guidance</b>: Organic revenue growth: at least 3%; Core EPS: $5.65; Tax rate: 19% to 20%; Net capital expenditure: ~$3.3B; Cash flow from operating activities: ~$9B; Free cash flow: ~$6B.</li><li>PEP<font color='red'>&nbsp;-0.71%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3394314-pepsico-beats-0_02-beats-revenue\" target=\"_blank\">PepsiCo beats by $0.02, beats on revenue</a> (Oct. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3394323\" data-linked=\"PepsiCo beats Q3 estimates, revised FY2018 guidance\" data-tweet=\"$PEP - PepsiCo beats Q3 estimates, revised FY2018 guidance https://seekingalpha.com/news/3394323-pepsico-beats-q3-estimates-revised-fy2018-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3394323-pepsico-beats-q3-estimates-revised-fy2018-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":65,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}